SCHEMBL1882237

SCHEMBL1882237

C=Cc1ccc(C2=CCC2)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.52
TSHR P16473 1/20 0.40
TDP1 Q9NUW8 1/20 0.35
HDAC8 Q9BY41 1/20 0.34
DAPK3 O43293 1/20 0.32
JAK2 O60674 1/20 0.32
ABL1 P00519 1/20 0.32
NTRK1 P04629 1/20 0.32
FYN P06241 1/20 0.32
CSF1R P07333 1/20 0.32
RET P07949 1/20 0.32
MET P08581 1/20 0.32
PDGFRB P09619 1/20 0.32
FGFR1 P11362 1/20 0.32
FLT3 P36888 1/20 0.32
MAPK8 P45983 1/20 0.32
GSK3B P49841 1/20 0.32
CDK9 P50750 1/20 0.32
RPS6KA3 P51812 1/20 0.32
LIMK1 P53667 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10492857 0.85 ALDH1A1 (0.46) ALDH1A1TSHRTDP1HDAC8PDGFRB
SCHEMBL10492496 0.83 ALDH1A1 (0.44) ALDH1A1TSHRTDP1JAK2
SCHEMBL3981331 0.77 TP53 (0.44) ALDH1A1TSHRTDP1
SCHEMBL6047065 0.76 CYP2A6 (0.42) ALDH1A1
SCHEMBL583978 0.76 ALDH1A1 (0.79) ALDH1A1TSHRTDP1HDAC8DAPK3
SCHEMBL593791 0.76 ALDH1A1 (0.79) ALDH1A1TSHRTDP1HDAC8DAPK3
SCHEMBL8057972 0.76 HTR2C (0.59) ALDH1A1
Water SCHEMBL7178879 0.73 ALDH1A1 (0.73) ALDH1A1TSHRTDP1HDAC8DAPK3
SCHEMBL473081 0.72 ALDH1A1 (1.00) ALDH1A1TSHRTDP1HDAC8DAPK3
SCHEMBL7639 0.72 ALDH1A1 (1.00) ALDH1A1TSHRTDP1HDAC8DAPK3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 757 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260076803-A1 POLYISOBUTYLENE-BASED POLYURETHANES FOR MEDICAL IMPLANT DEVICES INNOVIA, INC. (US) 2026-03-19 US claimed
WO-2026041747-A1 CARBON AND SILICONE ENRICHED NEW HIGH-CHI BLOCK COPOLYMERS OF NOVEL ARCHITECTURES FOR THIN-FILM SELF-ASSEMBLY APPLICATIONS MERCK PATENT GMBH (DE) 2026-02-26 WO claimed
US-12509540-B2 Development of novel neutral layer and hydrophobic pinning mat materials for use in DSA with improved substrate compatibility MERCK PATENT GMBH (DE) 2025-12-30 US claimed
EP-4186584-B1 METHOD FOR CROSS-LINKING OF POLYMERIC MEMBRANES HELMHOLTZ ZENTRUM HEREON GMBH (DE) 2025-09-17 EP claimed
CN-119219828-B PMI foam with high toughness, high strength and high temperature resistance 浙江中科恒泰新材料科技有限公司 2025-06-24 CN claimed
CN-119930902-B Solid optical material and preparation method thereof 像航(上海)科技有限公司 2025-06-17 CN claimed
CN-119612458-B Synthesis process of gamma-phase indium selenide 西北工业大学 2025-05-30 CN claimed
CN-119930902-A Solid optical material and preparation method thereof 像航(上海)科技有限公司 2025-05-06 CN claimed
CN-119612458-A Synthesis process of gamma-phase indium selenide 西北工业大学 2025-03-14 CN claimed
EP-4519335-A1 DEVELOPMENT OF NOVEL NEUTRAL MATS CONTAINING HYDROXYL MONOMERS TO IMPROVE SIARC SUBSTRATE COMPATIBILITY FOR DIRECTED SELF-ASSEMBLY OF DIBLOCK COPOLYMERS Merck Patent GmbH (DE) 2025-03-12 EP claimed
EP-0227124-B2 Olefinic benzocyclobutene polymers and processes for the preparation thereof SHELL INT RESEARCH (NL) 1996-01-31 EP claimed
EP-0527508-A2 Arylcyclobutene monomers and polymers THE DOW CHEMICAL COMPANY (a Delaware corporation) (US) 1993-02-17 EP claimed
EP-0425814-A1 Syndiotactic polymers from arylcyclobutene functional monomers, process for preparation and crosslinked derivatives thereof THE DOW CHEMICAL COMPANY (US) 1991-05-08 EP claimed
US-4968754-A FROM REACTION OF MALEIC ACID DERIVATIVE WITH BENZOCYCLOBUTENE MOIETY SHELL OIL COMPANY (US) 1990-11-06 US claimed
US-4722974-A POLYMERIZED WITH UNSATURATED AROMATIC HYDROCARBON AND CONJUGATED DIENES; CROSSLINKABLE; SOLVENT RESISTANT SHELL OIL COMPANY (US) 1988-02-02 US claimed
US-4698394-A OLEFINIC BENZOCYCLOBUTENE COMONOMERS, GRAFTING, CROSSLINKING SHELL OIL COMPANY (US) 1987-10-06 US claimed
WO-1987005303-A1 COMPOSITIONS COMPRISING ARYLCYCLOBUTENE AND POLYMERIC COMPOSITIONS PREPARED THEREFROM THE DOW CHEMICAL COMPANY (US) 1987-09-11 WO claimed
US-4687815-A Hydrogenated block copolymers SHELL OIL COMPANY (US) 1987-08-18 US claimed
EP-0227124-A2 Olefinic benzocyclobutene polymers and processes for the preparation thereof SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) 1987-07-01 EP claimed
US-4622375-A Amorphous ethylene/propylene polymers SHELL OIL COMPANY (US) 1986-11-11 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12509540-B2 Development of novel neutral layer and hydrophobic pinning mat materials for use in DSA with improved substrate compatibility SMC2, RAD51, SMC1A ALDH1A1 1882/4885TSHR 810/4885TDP1 1083/4885
US-20260076803-A1 POLYISOBUTYLENE-BASED POLYURETHANES FOR MEDICAL IMPLANT DEVICES TNNC1, TNNI3, MYLK2 ALDH1A1 1391/4885TSHR 3356/4885TDP1 1860/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.